Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 CAD | -7.69% | +9.09% | -14.29% |
May. 15 | Resverlogix Corp. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Apr. 01 | Resverlogix Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
12.11M | - | - | - | - | - | |
115B | ||||||
106B | ||||||
21.96B | - | |||||
21.84B | - | |||||
19.21B |
- Stock Market
- Equities
- RVX Stock
- Charts Resverlogix Corp.
- Sector Chart